Syringes and Needles Market Size, Share, Industry, Forecast and outlook (2024-2031)

Global Syringes and Needles Market is segmented By Product Type (Blood Collection Syringes & Needles, Ophthalmic Syringes & Needles, Bone Marrow Syringes & Needles, Catheter Syringes & Needles, Dental Syringes & Needles, Spinal Anesthesia Syringes & Needles, Suture Syringes & Needles, Others), By Usability (Disposable, Reusable), By Capacity (1 mL Syringe, 2- 3 mL Syringe, 5 mL Syringe, 10 mL Syringe), By Age Group (Pediatrics, Adults, Geriatric), By Application (General Surgery, Respiratory, Orthopedics, Cardiovascular, Dental, Neurology, Ophthalmology, Urology, Others), By End-User (Hospital & Specialty Clinics, Diagnostic Centers, Homecare Settings, Others) and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2024-2031

Report Overview

The Global Syringes and Needles Market reached US$ 8.27 billion in 2023 and is expected to reach US$ 13.59 billion by 2031 growing with a CAGR of 6.4% during the forecast period 2024-2031.

Syringes are essential medical devices used for administering medications and collecting bodily fluids. They are specifically designed to either inject fluids into the body or extract them, making them vital tools in a variety of healthcare environments.

Needles are sharp, pointed instruments essential for delivering medications or drawing blood, typically used alongside syringes. They are crucial in various medical procedures and come in several types, each designed for specific applications based on their design and intended use.

Both syringes and needles are fundamental components of modern healthcare, facilitating the safe and effective delivery of medications, vaccines, and blood collection. Their design and functionality are continuously advancing to enhance patient comfort, improve safety, and minimize the risk of infections and injuries.

Market Scope

For more details on this report - Request for Sample

Market Dynamics: Drivers

Increasing prevalence of chronic diseases and technological advancements

Multiple factors drive the demand for the global syringes and needles market. One of the primary factors is the increasing prevalence of chronic diseases and technological advancements. The increasing prevalence of chronic diseases is a major driver for the growing demand for syringes and needles globally. Chronic conditions such as diabetes, cancer, and cardiovascular diseases require regular medication administration, often through injections, which is fueling the need for injection devices. 

As the number of patients requiring regular injections increases, manufacturers are responding with innovative products and solutions to meet this rising need. Patients with these conditions often require regular injections for medication management, which leads to a growing need for user-friendly and efficient devices. Innovations in syringe and needle design are significantly enhancing patient comfort and safety, leading to increased acceptance and usage of these devices in clinical settings. These advancements include the development of safety needles and technologies that minimize pain during injections.

Moreover, key players in the industry have innovative product launches and technological advancements that would drive this market growth. For instance, in November 2023, Terumo India introduced a new Insulin Syringe specifically designed for patients who require daily insulin injections to manage diabetes. This product is part of the Life Care Solutions division of Terumo Medical Care Solutions and aims to enhance patient comfort and ease of use during insulin administration.

Similarly, in September 2022, Terumo India announced the launch of FineGlide, a sterile pen needle designed for patients who require regular insulin injections or other forms of self-medication. This new needle is compatible with the most commonly used pen devices available in India, enhancing patient comfort and promoting better adherence to medication regimens.

Restraints

Factors such as product recalls, stringent regulatory policies and regulations, injuries and infection risks associated with the needlestick, and adoption of alternative drug delivery technologies,  are expected to hamper the market.

Market Segment Analysis

The global syringes and needles market is segmented based on product type, usability, capacity, age group, application, end-user, and region.

The blood collection syringes & needle segment accounted for approximately 51.8% of the global syringes and needles market share

The blood collection syringes & needles segment is expected to hold the largest market share over the forecast period. This segment is driven by the growing need for diagnostic testing and patient monitoring. As this market continues to evolve, innovations in design and technology will play a pivotal role in enhancing safety and efficiency, ultimately improving patient outcomes and healthcare delivery.

Blood collection syringes and needles are essential medical devices specifically engineered to facilitate the safe and efficient withdrawal of blood from patients. Their design and functionality are critical in various healthcare settings, including hospitals, blood banks, and diagnostic laboratories.

Moreover, key players in the industry more focus on developing innovative syringes & needles and product approvals that would propel this segment's growth in the market. For instance, in April 2024, to reduce patient pain and discomfort while ensuring successful blood collection with a single prick, BD launched the BD Vacutainer UltraTouch Push Button Blood Collection Set in India. This innovative set incorporates BD RightGauge technology, which allows for the use of a thinner needle and is combined with BD PentaPoint Technology, significantly decreasing insertion pain for patients. Additionally, the BD Vacutainer UltraTouch features BD Push Button Technology, which lowers the risk of needle injuries by 88%.

Similarly, in November 2023,  BD introduced the PIVO Pro Needle-free Blood Collection Device, which received 510(k) clearance from the U.S. Food and Drug Administration (FDA). This new device is designed to be compatible with integrated catheters, further enabling BD's "One-Stick Hospital Stay" vision.

Market Geographical Share

North America accounted for approximately 43.6% of the global syringes and needles market share

North America region is expected to hold the largest market share over the forecast period owing to the increasing incidence of chronic diseases such as diabetes, cardiovascular diseases, and cancer is a significant driver of the syringes and needles market in North America. Patients suffering from chronic diseases frequently need to receive regular injections to manage their medications. People with diabetes must administer insulin several times each day, which directly boosts the demand for syringes.

Moreover, growing demand for injectable drugs, technological advancements, increased adoption of home healthcare, regulatory support &  growing awareness among individuals, and product approvals, are driving the market growth in the region.  

In addition, in this region, a major number of key players' presence, well-advanced healthcare infrastructure, key player's product launches, and approvals would drive this market growth. For instance, in March 2024, the U.S. Food and Drug Administration's (FDA) ongoing evaluation of certain plastic syringes, particularly those manufactured in China, BD (Becton, Dickinson, and Company) has announced that it is increasing domestic production of syringes in its facilities located in Nebraska and Connecticut.

Similarly, in March 2024, the U.S. Food and Drug Administration (FDA) concerning the safety of plastic syringes and safety needles produced in China, HTL-Strefa Inc. is pleased to provide healthcare providers, facilities, and consumers with a reliable and safe alternative. Their FDA-cleared, European-manufactured passive safety needle, DropSafe Sicura, exemplifies the highest standards of safety, reliability, and performance, ensuring alignment with optimal patient care and safety practices.

Also, in February 2023, Zephyrus Innovations, a privately-owned medical device company, announced that it had received its first 510(k) Marketing Approval from the U.S. Food and Drug Administration (FDA) for its Aeroject 3ml safety syringe. This approval marks a significant milestone for the company, allowing it to market the Aeroject syringe, which is designed to enhance safety for healthcare professionals and patients alike.

Market Segmentation

By Product Type

• Blood Collection Syringes & Needles
• Ophthalmic Syringes & Needles
• Bone Mas these arrow Syringes & Needles
• Catheter Syringes & Needles
• Dental Syringes & Needles
• Spinal Anesthesia Syringes & Needles
•  Suture Syringes & Needles
• Others

By Usability 

• Disposable
•  Reusable

By Capacity

• 1 mL Syringe
•  2- 3 mL Syringe
• 5 mL Syringe
• 10 mL Syringe

By Age Group

• Pediatrics
• Adults
• Geriatric

 By Application 

• General Surgery
• Respiratory
• Orthopedics
• Cardiovascular
•  Dental
•  Neurology
• Ophthalmology
• Urology
• Others 

By End User 

• Hospital & Specialty Clinics
• Diagnostic Centers
• Homecare Settings
• Others

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Rest of Europe
• South America
  • Brazil
  • Argentina
  • The rest of South America
• Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Middle East and Africa

Market Competitive Landscape

The major global players in the syringes and needles market include BD, B. Braun SE, Cardinal Health, Terumo Medical Corporation, Gerresheimer AG, Nipro Corporation, SCHOTT Pharma AG & Co. KGaA, Hindustan Syringes & Medical Devices Ltd, ICU Medical, Inc., and Catalent, Inc among others.

Key Developments

• In March 2024, Hindustan Syringes and Medical Devices (HMD), a major manufacturer of disposable and auto-disable syringes in India, launched Dispojekt - an indigenous single-use safety syringe designed to reduce the incidence of needle stick injuries (NSIs) among healthcare workers. A needle stick injury (NSI) occurs when a hollow-bore needle accidentally penetrates the skin and potentially exposes the healthcare worker to another person's blood or body fluid. These injuries pose a serious risk of transmission of bloodborne pathogens such as hepatitis B, hepatitis C, and HIV.
• In October 2022, Terumo Pharmaceutical Solutions (TPS), launched the PLAJEX 2.25 mL with Tapered Needle, a ready-to-fill polymer syringe specifically designed for the biotech market. This innovative syringe addresses the unique challenges associated with delivering complex biotech drugs, particularly those with larger volumes and high viscosity, such as concentrated monoclonal antibodies.

Why Purchase the Report?

• To visualize the global syringes and needles market segmentation based on product type, usability, capacity, age group, application, end-user, and region and understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development. 
• Excel data sheet with numerous data points of the syringes and needles market with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping is available in excel consisting of key products of all the major players.

The global syringes and needles market report would provide approximately 86 tables, 94 figures, and 184 pages.

Target Audience 2024

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies